Prothena Corporation plc (NASDAQ:PRTA) shares, rose in value on Friday, July 11, with the stock price down by -2.59% to the previous day’s close as strong demand from buyers drove the stock to $6.4.
Actively observing the price movement in the last trading, the stock closed the session at $6.57, falling within a range of $6.31 and $6.52. The value of beta (5-year monthly) was -0.079. Referring to stock’s 52-week performance, its high was $25.42, and the low was $4.32. On the whole, PRTA has fluctuated by 21.67% over the past month.
With the market capitalization of Prothena Corporation plc currently standing at about $344.49 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 6.18M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PRTA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PRTA currently trading nearly 5.96% and 1.91% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.79, while the 7-day volatility ratio is showing 4.09% which for the 30-day chart, stands at 6.08%. Furthermore, Prothena Corporation plc (PRTA)’s beta value is -0.04.
A comparison of Prothena Corporation plc (PRTA) with its peers suggests the former has fared considerably weaker in the market. PRTA showed an intraday change of -2.59% in last session, and over the past year, it shrunk by -53.79%%.
Data on historical trading for Prothena Corporation plc (NASDAQ:PRTA) indicates that the trading volumes over the past 10 days have averaged 1.11 and over the past 3 months, they’ve averaged 1.78 million. According to company’s latest data on outstanding shares, there are 53.83 million shares outstanding.
Nearly 21.38% of Prothena Corporation plc’s shares belong to company insiders and institutional investors own 70.17% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.66 million shares as on 2025-06-13, resulting in a short ratio of 2.24. According to the data, the short interest in Prothena Corporation plc (PRTA) stood at 1627.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 8.95 million. The stock has fallen by -68.95% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PRTA stock heading into the next quarter.
